BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2056278)

  • 1. Antibody recognition of an immunogenic influenza hemagglutinin-human leukocyte antigen class II complex.
    Nygard NR; Bono C; Brown LR; Gorka J; Giacoletto KS; Schaiff WT; Graham MB; McCourt DW; Kabeer M; Braciale VL
    J Exp Med; 1991 Jul; 174(1):243-51. PubMed ID: 2056278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide binding to surface class II molecules is the major pathway of formation of immunogenic class II-peptide complexes for viable antigen presenting cells.
    Nygard NR; Giacoletto KS; Bono C; Gorka J; Kompelli S; Schwartz BD
    J Immunol; 1994 Feb; 152(3):1082-93. PubMed ID: 8301118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition.
    Brown LR; Nygard NR; Graham MB; Bono C; Braciale VL; Gorka J; Schwartz BD; Braciale TJ
    J Immunol; 1991 Oct; 147(8):2677-84. PubMed ID: 1717572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice.
    Yamamoto K; Fukui Y; Esaki Y; Inamitsu T; Sudo T; Yamane K; Kamikawaji N; Kimura A; Sasazuki T
    J Exp Med; 1994 Jul; 180(1):165-71. PubMed ID: 8006580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six unrelated HLA-DR-matched adults recognize identical CD4+ T cell epitopes from influenza A haemagglutinin that are not simply peptides with high HLA-DR binding affinities.
    Gelder C; Davenport M; Barnardo M; Bourne T; Lamb J; Askonas B; Hill A; Welsh K
    Int Immunol; 1998 Feb; 10(2):211-22. PubMed ID: 9533449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of the class II (I-Ak/I-Ek)-restricted T cell repertoire for influenza hemagglutinin and antigenic drift. Six nonoverlapping epitopes on the HA1 subunit are defined by synthetic peptides.
    Burt DS; Mills KH; Skehel JJ; Thomas DB
    J Exp Med; 1989 Aug; 170(2):383-97. PubMed ID: 2474053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine specificity of murine class II-restricted T cell clones for synthetic peptides of influenza virus hemagglutinin. Heterogeneity of antigen interaction with the T cell and the Ia molecule.
    Mills KH; Burt DS; Skehel JJ; Thomas DB
    J Immunol; 1988 Jun; 140(12):4083-90. PubMed ID: 2453566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I-Ad restricted T cell recognition of influenza hemagglutinin. Synthetic peptides identify multiple epitopes corresponding to antibody-binding regions of the HA1 subunit.
    Barnett BC; Burt DS; Graham CM; Warren AP; Skehel JJ; Thomas DB
    J Immunol; 1989 Oct; 143(8):2663-9. PubMed ID: 2477451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of soluble fusion proteins for induction of T cell proliferation.
    Kirschmann DA; De Ciechi PA; Bono CP; Zacheis ML; Schwartz BD; Woulfe SL
    Cell Immunol; 1995 Feb; 160(2):193-8. PubMed ID: 7720079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen.
    Milligan GN; Morrison LA; Gorka J; Braciale VL; Braciale TJ
    J Immunol; 1990 Nov; 145(10):3188-93. PubMed ID: 1700000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human CD4+ T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection.
    Gelder CM; Welsh KI; Faith A; Lamb JR; Askonas BA
    J Virol; 1995 Dec; 69(12):7497-506. PubMed ID: 7494256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses.
    Lechler RI; Heaton T; Barber L; Bal V; Batchelor JR; Lombardi G
    Immunol Lett; 1992 Sep; 34(1):63-9. PubMed ID: 1478706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of monoclonal antibodies to a synthetic peptide of influenza haemagglutinin on the processing and presentation of viral antigens to class II-restricted T-cell clones.
    Mills KH
    Immunology; 1988 Nov; 65(3):365-71. PubMed ID: 2463222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A T-cell clone recognizing an MLC stimulating epitope located on the DRw11 beta 1 chain.
    Urlacher A; Tiercy JM; Schlesier M; Steimle V; Peter H; Jeannet M; Mach B; Tongio MM
    Hum Immunol; 1989 Dec; 26(4):321-32. PubMed ID: 2479627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine cell lines stably expressing the influenza virus hemagglutinin gene introduced by a recombinant retrovirus vector are constitutive targets for MHC class I- and class II-restricted T lymphocytes.
    Eager KB; Hackett CJ; Gerhard WU; Bennink J; Eisenlohr LC; Yewdell J; Ricciardi RP
    J Immunol; 1989 Oct; 143(7):2328-35. PubMed ID: 2789261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic structure of the influenza virus hemagglutinin.
    Green N; Alexander H; Olson A; Alexander S; Shinnick TM; Sutcliffe JG; Lerner RA
    Cell; 1982 Mar; 28(3):477-87. PubMed ID: 6176330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces.
    Busch R; Strang G; Howland K; Rothbard JB
    Int Immunol; 1990; 2(5):443-51. PubMed ID: 1707655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of T cell proliferation by antibodies to synthetic peptides.
    Lamb JR; Zanders ED; Lake P; Webster RG; Eckels DD; Woody JN; Green N; Lerner RA; Feldmann M
    Eur J Immunol; 1984 Feb; 14(2):153-7. PubMed ID: 6607839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin.
    Wabuke-Bunoti MA; Taku A; Fan DP; Kent S; Webster RG
    J Immunol; 1984 Oct; 133(4):2194-201. PubMed ID: 6206156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody with broad anti-HLA-DR activity fails to bind to DRw11/Dw5: possible effect of a unique polymorphism on the beta 1 domain alpha-helix.
    Mackworth-Young CG; Kevany M; Lombardi G; Sidhu S; Sharrock C; Batchelor JR; Lechler RI
    Hum Immunol; 1991 Mar; 30(3):174-82. PubMed ID: 2055782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.